Search For "mild"
Jamaat congregation: Delhi court allows nationals from Kenya, Mali, Sri La
Updated : 5 years, 8 months ago IST
New Delhi [India], July 14 (ANI): A Delhi court on Tuesday allowed some foreign nationals from Kenya, Mali, and Sri Lanka to walk free on plea bargaining after they accepted mild charges in connection with the case related to the Tablighi Jamaat congregation in Nizamuddin area.
Read More
Delhi court allows foreign Jamaat attendees who accepted mild charges to w
Updated : 5 years, 8 months ago IST
New Delhi [India], July 13 (ANI): A Delhi court on Monday allowed foreign nationals from 14 countries including the UK, Algeria, Belgium, and others, who have accepted mild charges in connection with the Tablighi Jamaat congregation at Nizamuddin, to walk free.
Read More
Glenmark cuts COVID-19 drug Favipiravir price by 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
Read More
Amitabh Bachchan stable with mild symptoms after testing positive for COVI
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 12 (ANI): Megastar Amitabh Bachchan is reported to be in a "stable" condition with "mild symptoms" after testing positive for coronavirus on Saturday.
Read More
Odisha: BMC issues home isolation SOP for asymptomatic and mild symptomati
Updated : 5 years, 8 months ago IST
Bhubaneswar (Odisha) [India], July 11 (ANI): As COVID-19 cases continue to rise, the Bhubaneswar Municipal Corporation (BMC) has issued a Standard Operating Procedure (SOP) on home isolation of asymptomatic and mild symptomatic cases.
Read More
COVID-19: Karnataka govt issues new guidelines for home isolation of asymp
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 3 (ANI): Karnataka Government on Wednesday issued the guidelines for home isolation of COVID-19 patients in the state.
Read More
People with mild, medium colour blindness can now obtain driving licence
Updated : 5 years, 8 months ago IST
New Delhi [India], June 26 (ANI): The Road Transport and Highways Ministry has issued a notification to enable citizens with mild to medium colour blindness to obtain a driving licence.
Read More
Bengaluru: Floor in Sri Sri Ravishankar Ashram reserved for COVID-19 affec
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], June 25 (ANI): A floor in Sri Sri Ravishankar Ashram on Kanakpura Road here has been reserved for asymptomatic and mild symptomatic police personnel infected with COVID-19, the Karnataka government said on Wednesday.
Read More
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderat
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate C
Updated : 5 years, 8 months ago IST
New Delhi [India], June 20 (ANI): Domestic pharmaceuticals Glenmark on Saturday informed that their antiviral drug -- Favipiravir -- has shown clinical improvement of up to 88 per cent in mild to moderate COVID-19 cases, including those with co-morbidities.
Read More
Study reveals babies with COVID-19 tend to have mild illness, mostly with
Updated : 5 years, 8 months ago IST
Chicago (Illinois) [USA], June 20 (ANI): Infants under 90 days of age who tested positive for COVID-19 tend to be well, with little or no respiratory involvement and fever is often found to be the primary or only symptom, says a new study.
Read More
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' i
Updated : 5 years, 8 months ago IST
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
Read More